Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3733 to 3734 of 3734 entries
Sorted by: Best Match Show Resources per page
Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study.

Cancer medicine

Hwang K, Kim J, Kang SG, Jung TY, Kim JH, Kim SH, Kang SH, Hong YK, Kim TM, Kim YJ, Choi BS, Chang JH, Kim CY.
PMID: 34845868
Cancer Med. 2022 Jan;11(2):371-379. doi: 10.1002/cam4.4454. Epub 2021 Nov 30.

BACKGROUND: An open-label single-arm phase 2 study was conducted to evaluate the role of levetiracetam as a sensitizer of concurrent chemoradiotherapy (CCRT) for patients with newly diagnosed glioblastoma. This study aimed to determine the survival benefit of levetiracetam in...

Cite
Hwang K, Kim J, Kang SG, et al. Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study. Cancer Med. 2021;11(2):371-379doi: 10.1002/cam4.4454.
Hwang, K., Kim, J., Kang, S. G., Jung, T. Y., Kim, J. H., Kim, S. H., Kang, S. H., Hong, Y. K., Kim, T. M., Kim, Y. J., Choi, B. S., Chang, J. H., & Kim, C. Y. (2022). Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study. Cancer medicine, 11(2), 371-379. https://doi.org/10.1002/cam4.4454
Hwang, Kihwan, et al. "Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study." Cancer medicine vol. 11,2 (2022): 371-379. doi: https://doi.org/10.1002/cam4.4454
Hwang K, Kim J, Kang SG, Jung TY, Kim JH, Kim SH, Kang SH, Hong YK, Kim TM, Kim YJ, Choi BS, Chang JH, Kim CY. Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study. Cancer Med. 2022 Jan;11(2):371-379. doi: 10.1002/cam4.4454. Epub 2021 Nov 30. PMID: 34845868; PMCID: PMC8729048.
Copy Download .nbib Format: NLM
Predictors of well-being during the COVID-19 pandemic: The importance of financial satisfaction and neuroticism.

Journal of community psychology

Ng W, Kang SH.
PMID: 35032402
J Community Psychol. 2022 Jan 15; doi: 10.1002/jcop.22795. Epub 2022 Jan 15.

Current research suggests that the COVID-19 pandemic adversely impacts well-being. This study examined how subjective well-being (SWB) and psychological well-being (PWB) in Singapore were affected during the pandemic, and the factors that were important to SWB. A representative sample...

Cite
Ng W, Kang SH. Predictors of well-being during the COVID-19 pandemic: The importance of financial satisfaction and neuroticism. J Community Psychol. 2022;doi: 10.1002/jcop.22795.
Ng, W., & Kang, S. H. (2022). Predictors of well-being during the COVID-19 pandemic: The importance of financial satisfaction and neuroticism. Journal of community psychology, . https://doi.org/10.1002/jcop.22795
Ng, Weiting, and Kang, Soon-Hock. "Predictors of well-being during the COVID-19 pandemic: The importance of financial satisfaction and neuroticism." Journal of community psychology vol. (2022). doi: https://doi.org/10.1002/jcop.22795
Ng W, Kang SH. Predictors of well-being during the COVID-19 pandemic: The importance of financial satisfaction and neuroticism. J Community Psychol. 2022 Jan 15; doi: 10.1002/jcop.22795. Epub 2022 Jan 15. PMID: 35032402.
Copy Download .nbib Format: NLM
Showing 3733 to 3734 of 3734 entries